We further divided all patients into five pathological subgroups (DLBCL, MALT lymphoma, FL, T-cell lymphoma, and other B-cell lymphoma) to examine the major laboratory indicators and found that the LDH and ADA levels fluctuated significantly in patients with DLBCL. The gene discussed is ADA; the disease is T-cell non-Hodgkin lymphoma.